Global Organic Pharmaceutical Excipients Market Size is valued at USD 10.2 Billion in 2024 and is predicted to reach USD 27.6 Billion by the year 2034 at an 10.7% CAGR during the forecast period for 2025-2034.
Organic pharmaceutical excipients are naturally used in supplements to active medicinal compounds in producing pharmaceutical products. They come from renewable resources, such as microbes, vegetation, or livestock, and are usually considered safe for medicinal applications. The market is expanding due to the increasing demand for organic and conventional products in pharmaceutical applications, as consumers are opting for items that are perceived as more environmentally friendly and safer. The demand for organic pharmaceutical excipients is also being driven by the increasing investment in research and development by both public and private entities. Pharmaceutical companies and academic institutions are collaborating to foster innovation, which leads to the creation of new excipients with superior functional properties. The competitive environment is enhanced and a consistent supply of cutting-edge organic excipients is guaranteed through this collaboration between industry and research, which in turn drives market expansion.
However, the pharmaceutical excipients industry is fraught with patent and trademark problems, especially as patenting innovative excipient technology can put smaller businesses and new competitors at a competitive disadvantage. Larger corporations limit access to these essential components when they get patents for novel excipients, is hindering smaller businesses' capacity to form and sell competitive goods. The market may become less competitive as a result, which might hinder the creation of novel formulations that could meet unmet medical requirements.
Some of the Key Players in the Organic Pharmaceutical Excipients Market:
The organic pharmaceutical excipients market is segmented based on type, function, and end-user. Based on the type, the market is segmented into oleochemicals, carbohydrates, petrochemicals, protein, and others. Based on the function, the market is segmented into coating agents, colorant disintegrates, and other functions. Based on the application, the market is segmented into oral formulations, topical formulations, parenteral formulations, and other applications.
Disintegrates are expected to hold a major global market share in 2021 in the organic pharmaceutical excipients market because of their capacity to preserve drugs' effectiveness while improving their protection. Since organic disintegrants have quicker disintegration circumstances and better patient compliance, their use is being fueled by a growing emphasis on ease of use and better therapeutic results. Expanding possibilities for organic excipients in intricate medication formulations are anticipated as a result of the ongoing advancements in disintegrant technologies.
The oral formulations segment is growing in the organic pharmaceutical excipients market due to patient acceptance and their simplicity of use. Because organic excipients have superior security profiles and higher absorption, there is an increasing need for them in oral formulations. The popularity of organic excipients is being further fueled by the invention of novel forms of ingestion, especially controlled-release formulations and fast-dissolving tablets, which make it easier to produce more patient-friendly and reliable treatments.
The North American organic pharmaceutical excipients market is predicted to register the highest market share in revenue shortly. The regional growth can be attributed to its substantial priority for inventiveness, sophisticated research infrastructure, and thriving pharmaceutical business. The development of organic excipients is encouraged by the legal framework in the area, where organizations such as the FDA promote safer and more sustainable pharmacological components. In addition, the Asia Pacific is expected to develope rapidly in the organic pharmaceutical excipients market because of the expanding manufacturing of the medications industry, the population that is expanding quickly, and greater awareness of medical concerns. Organic excipients are becoming more and more popular in the area due to increasing consumer preference for goods that are organic and natural, as well as a greater focus on safety and effectiveness.
Report Attribute |
Specifications |
Market Size Value In 2024 |
USD 10.2 Billion |
Revenue Forecast In 2034 |
USD 27.6 Billion |
Growth Rate CAGR |
CAGR of 10.7% from 2025 to 2034 |
Quantitative Units |
Representation of revenue in US$ Mn and CAGR from 2025 to 2034 |
Historic Year |
2021 to 2024 |
Forecast Year |
2025-2034 |
Report Coverage |
The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends |
Segments Covered |
By Type, Function, Application |
Regional Scope |
North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
Country Scope |
U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico; The UK; France; Italy; Spain; China; Japan; India; South Korea; Southeast Asia; South Korea; Southeast Asia |
Competitive Landscape |
Roquette Freres SA, DuPont de Nemours Inc., Ashland Inc, BASF SE, Kerry, Group plc, Evonik Industries AG, Croda International plc, The Lubrizol Corporation, Innophos Holdings Inc, Wacker Chemie AG |
Customization Scope |
Free customization report with the procurement of the report and modifications to the regional and segment scope. Geographic competitive landscape. |
Pricing and Available Payment Methods |
Explore pricing alternatives that are customized to your particular study requirements. |
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Organic Pharmaceutical Excipients Market Snapshot
Chapter 4. Global Organic Pharmaceutical Excipients Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Porter's Five Forces Analysis
4.7. Incremental Opportunity Analysis (US$ MN), 2024-2034
4.8. Competitive Landscape & Market Share Analysis, By Key Player (2023)
4.9. Use/impact of AI on Organic Pharmaceutical Excipients Market Industry Trends
4.10. Global Organic Pharmaceutical Excipients Market Penetration & Growth Prospect Mapping (US$ Mn), 2021-2034
Chapter 5. Organic Pharmaceutical Excipients Market Segmentation 1: By Type, Estimates & Trend Analysis
5.1. Market Share By Type, 2024 & 2034
5.2. Market Size Revenue (US$ Million) & Forecasts and Trend Analyses, 2021 to 2034 for the following Product Type:
5.2.1. Oleochemicals
5.2.2. Carbohydrates
5.2.3. Petrochemicals
5.2.4. Protein
5.2.5. Other
Chapter 6. Organic Pharmaceutical Excipients Market Segmentation 2: By Function, Estimates & Trend Analysis
6.1. Market Share By Function, 2024 & 2034
6.2. Market Size Revenue (US$ Million) & Forecasts and Trend Analyses, 2021 to 2034 for the following Source:
6.2.1. Binders
6.2.2. Coating Agents
6.2.3. Colorants
6.2.4. Disintegrates
6.2.5. Other Functions
Chapter 7. Organic Pharmaceutical Excipients Market Segmentation 3: By Application, Estimates & Trend Analysis
7.1. Market Share By Application, 2024 & 2034
7.2. Market Size Revenue (US$ Million) & Forecasts and Trend Analyses, 2021 to 2034 for the following Animal Type:
7.2.1. Oral Formulations
7.2.2. Topical Formulations
7.2.3. Parenteral Formulations
7.2.4. Other Applications
Chapter 8. Organic Pharmaceutical Excipients Market Segmentation 5: Regional Estimates & Trend Analysis
8.1. Global Organic Pharmaceutical Excipients Market, Regional Snapshot 2024 & 2034
8.2. North America
8.2.1. North America Organic Pharmaceutical Excipients Market Revenue (US$ Million) Estimates and Forecasts by Country, 2021-2034
8.2.1.1. US
8.2.1.2. Canada
8.2.2. North America Organic Pharmaceutical Excipients Market Revenue (US$ Million) Estimates and Forecasts By Type, 2021-2034
8.2.3. North America Organic Pharmaceutical Excipients Market Revenue (US$ Million) Estimates and Forecasts By Function, 2021-2034
8.2.4. North America Organic Pharmaceutical Excipients Market Revenue (US$ Million) Estimates and Forecasts By Application, 2021-2034
8.3. Europe
8.3.1. Europe Organic Pharmaceutical Excipients Market Revenue (US$ Million) Estimates and Forecasts by Country, 2021-2034
8.3.1.1. Germany
8.3.1.2. U.K.
8.3.1.3. France
8.3.1.4. Italy
8.3.1.5. Spain
8.3.1.6. Rest of Europe
8.3.2. Europe Organic Pharmaceutical Excipients Market Revenue (US$ Million) Estimates and Forecasts By Type, 2021-2034
8.3.3. Europe Organic Pharmaceutical Excipients Market Revenue (US$ Million) Estimates and Forecasts By Function, 2021-2034
8.3.4. Europe Organic Pharmaceutical Excipients Market Revenue (US$ Million) Estimates and Forecasts By Application, 2021-2034
8.4. Asia Pacific
8.4.1. Asia Pacific Organic Pharmaceutical Excipients Market Revenue (US$ Million) Estimates and Forecasts by Country, 2021-2034
8.4.1.1. India
8.4.1.2. China
8.4.1.3. Japan
8.4.1.4. Australia
8.4.1.5. South Korea
8.4.1.6. Hong Kong
8.4.1.7. Southeast Asia
8.4.1.8. Rest of Asia Pacific
8.4.2. Asia Pacific Organic Pharmaceutical Excipients Market Revenue (US$ Million) Estimates and Forecasts By Type, 2021-2034
8.4.3. Asia Pacific Organic Pharmaceutical Excipients Market Revenue (US$ Million) Estimates and Forecasts By Function, 2021-2034
8.4.4. Asia Pacific Organic Pharmaceutical Excipients Market Revenue (US$ Million) Estimates and Forecasts By Application, 2021-20348.5. Latin America
8.5.1. Latin America Organic Pharmaceutical Excipients Market Revenue (US$ Million) Estimates and Forecasts by Country, 2021-2034
8.5.1.1. Brazil
8.5.1.2. Mexico
8.5.1.3. Rest of Latin America
8.5.2. Latin America Organic Pharmaceutical Excipients Market Revenue (US$ Million) Estimates and Forecasts By Type, 2021-2034
8.5.3. Latin America Organic Pharmaceutical Excipients Market Revenue (US$ Million) Estimates and Forecasts By Function, 2021-2034
8.5.4. Latin America Organic Pharmaceutical Excipients Market Revenue (US$ Million) Estimates and Forecasts By Application, 2021-2034
8.6. Middle East & Africa
8.6.1. Middle East & Africa Wind Turbine Rotor Blade Market Revenue (US$ Million) Estimates and Forecasts by country, 2021-2034
8.6.1.1. GCC Countries
8.6.1.2. Israel
8.6.1.3. South Africa
8.6.1.4. Rest of Middle East and Africa
8.6.2. Middle East & Africa Organic Pharmaceutical Excipients Market Revenue (US$ Million) Estimates and Forecasts By Type, 2021-2034
8.6.3. Middle East & Africa Organic Pharmaceutical Excipients Market Revenue (US$ Million) Estimates and Forecasts By Function, 2021-2034
8.6.4. Middle East & Africa Organic Pharmaceutical Excipients Market Revenue (US$ Million) Estimates and Forecasts By Application, 2021-2034
Chapter 9. Competitive Landscape
9.1. Major Mergers and Acquisitions/Strategic Alliances
9.2. Company Profiles
9.2.1. Roquette Freres SA
9.2.1.1. Business Overview
9.2.1.2. Key Product Type/Service Overview
9.2.1.3. Financial Performance
9.2.1.4. Geographical Presence
9.2.1.5. Recent Developments with Business Strategy
9.2.2. DuPont de Nemours Inc.
9.2.3. Ashland Inc.
9.2.4. BASF SE
9.2.5. Kerry Group plc
9.2.6. Evonik Industries AG
9.2.7. Croda International plc
9.2.8. The Lubrizol Corporation
9.2.9. Innophos Holdings Inc.
9.2.10. Wacker Chemie AG
Segmentation of Organic Pharmaceutical Excipients Market
Segmentation of Organic Pharmaceutical Excipients Market -By Type
Segmentation of Organic Pharmaceutical Excipients Market -By Function
Segmentation of Organic Pharmaceutical Excipients Market- By Application
Segmentation of Organic Pharmaceutical Excipients Market - By Region-
North America-
Europe-
Asia-Pacific-
Latin America-
Middle East & Africa-
InsightAce Analytic follows a standard and comprehensive market research methodology focused on offering the most accurate and precise market insights. The methods followed for all our market research studies include three significant steps – primary research, secondary research, and data modeling and analysis - to derive the current market size and forecast it over the forecast period. In this study, these three steps were used iteratively to generate valid data points (minimum deviation), which were cross-validated through multiple approaches mentioned below in the data modeling section.
Through secondary research methods, information on the market under study, its peer, and the parent market was collected. This information was then entered into data models. The resulted data points and insights were then validated by primary participants.
Based on additional insights from these primary participants, more directional efforts were put into doing secondary research and optimize data models. This process was repeated till all data models used in the study produced similar results (with minimum deviation). This way, this iterative process was able to generate the most accurate market numbers and qualitative insights.
Secondary research
The secondary research sources that are typically mentioned to include, but are not limited to:
The paid sources for secondary research like Factiva, OneSource, Hoovers, and Statista
Primary Research:
Primary research involves telephonic interviews, e-mail interactions, as well as face-to-face interviews for each market, category, segment, and subsegment across geographies
The contributors who typically take part in such a course include, but are not limited to:
Data Modeling and Analysis:
In the iterative process (mentioned above), data models received inputs from primary as well as secondary sources. But analysts working on these models were the key. They used their extensive knowledge and experience about industry and topic to make changes and fine-tuning these models as per the product/service under study.
The standard data models used while studying this market were the top-down and bottom-up approaches and the company shares analysis model. However, other methods were also used along with these – which were specific to the industry and product/service under study.
To know more about the research methodology used for this study, kindly contact us/click here.